Avid Bioservices, INC Form 4 insider transactions
Nicholas Green, President & CEO of Avid Bioservices, reports the acquisition and disposal of common stock and restricted stock units.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports acquisition and disposal of common stock and performance stock units.
Chief Commercial Officer Matthew Kwietniak reports acquisition and disposal of Avid Bioservices stock and performance stock units.
Chief Commercial Officer Matthew R. Kwietniak reports acquisition and disposal of Avid Bioservices stock units to satisfy tax obligations.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports the acquisition and disposal of common stock and restricted stock units related to vesting and tax obligations.
Mark R. Ziebell, V.P. and General Counsel of Avid Bioservices, Inc., reports the vesting and conversion of performance and restricted stock units.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports acquisition and disposal of common stock and derivative securities.
Chief Commercial Officer Matthew Kwietniak reports acquisition and disposal of Avid Bioservices stock and performance/restricted stock units.
Daniel R. Hart, CFO of Avid Bioservices, Inc., reports the vesting of performance and restricted stock units.
Nicholas Green, CEO of Avid Bioservices, reports acquisition and disposal of common stock and derivative securities, including performance stock units and restricted stock units.
Director Esther M. Alegria reports vesting of restricted stock units in Avid Bioservices, Inc.
Mark R. Ziebell, V.P. and General Counsel of Avid Bioservices, Inc., reports purchasing 1,965 shares of common stock at $5.406 per share through the company's Employee Stock Purchase Plan.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reports purchases of common stock under the company's Employee Stock Purchase Plan.
Form 4: Avid Bioservices CFO Daniel R. Hart Reports Stock Purchase Under Employee Stock Purchase Plan
Daniel R. Hart, CFO of Avid Bioservices, Inc., reports the purchase of common stock under the company's Employee Stock Purchase Plan.
Nicholas Green, President & CEO of Avid Bioservices, Inc., acquired 1,965 shares of common stock through the company's Employee Stock Purchase Plan (ESPP) at a price of $5.406 per share on June 28, 2024.
Mark R. Ziebell, VP and General Counsel of Avid Bioservices, sold 1,643 shares of common stock on April 30, 2024, to satisfy tax withholding obligations related to vested restricted stock units.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, Inc., reported selling shares of common stock to satisfy tax withholding obligations related to the vesting of restricted stock units.
Avid Bioservices' Chief Commercial Officer, Matthew Kwietniak, sold 1,233 shares of common stock on April 30, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock units.
Daniel Hart, CFO of Avid Bioservices, sold 2,826 shares of common stock on April 30, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock units.
Avid Bioservices CEO Nicholas Green sold 11,762 shares of common stock on April 30, 2024, to satisfy tax withholding obligations related to the vesting of restricted stock units.
Matthew Kwietniak, Chief Commercial Officer of Avid Bioservices, Inc., reports the vesting of restricted stock units.
Mark R. Ziebell, V.P. and General Counsel of Avid Bioservices, Inc., reports the vesting and conversion of restricted stock units into common stock.
Richard A. Richieri, Chief Operations Officer of Avid Bioservices, reported the vesting and conversion of restricted stock units into common stock, as well as transactions by spouse.
Chief Commercial Officer Matthew Kwietniak reports transactions involving restricted stock units of Avid Bioservices, Inc.
Daniel R. Hart, CFO of Avid Bioservices, Inc., reported the vesting of restricted stock units and subsequent acquisition of common stock on April 9, 2024.
Nicholas Green, President & CEO of Avid Bioservices, reports the vesting of restricted stock units and subsequent acquisition of common stock.